Experimental section
each measurement and a data pitch of 0.1 nm. Background CD spectrum of the solvent was recorded and subtracted form each spectrum.
Cytotoxicity was measured on human colon HT-29 (purchased from ATCC Inc.), human ovarian carcinoma A2780, human ovarian cisplatin-resistant carcinoma A2780cp, and human ovarian adriamycin-resistant carcinoma A2780adr (purchased from ECACC Inc.) cancer cell lines using the MTT assay as previously described. 4 Cells (0.6 x 10 6 ) in medium (containing 10% fetal bovine serum, 1% L-glutamine, 1% penicillin/streptomycin antibiotics and 88% Roswell Park Memorial Institute (RPMI) 1640 medium, purchased from Biological Industries Inc.) were seeded in 96 well plates (Thermo Scientific NUNC TM ) and were allowed to attach overnight. Following 1 day, the cells were treated with the tested compound or combination of different ratios of the pure enantiomers at 10 different concentrations and the cells were incubated for 3 days at 37 ˚C in 5% CO2 atmosphere. Consequently, MTT (0.1 mg in 20 µL) was added to the cells for additional incubation of 3 hours. The medium was then removed, 200 µL of isopropanol was added, and the absorbance was measured at 550 nm by Bio-Tek EL-800 microplate reader or by a Spark Hydrolysis studies by NMR were performed at room temperature as previously described, 5, 6 using ca. 3.6 mM of the complex solution in DMSO and adding >10000 equiv. of H2O to give a final solution of 9:1 H2O / DMSO. Following 17 days, the volatiles were removed by reduced pressure, the remaining mixture lyophilized, and a final spectrum was recorded in DMSO-d6. An additional hydrolysis study was performed in DMSO, adding >1000 equiv. of D2O to give a final solution of 9:1 DMSO / D2O, monitored over time by NMR, and calibrated to dinitrobenzene internal standard (Sigma Aldrich ltd.). The results are provided below.
Rac-LH4:
The ligand was synthesized based on a published procedure 1 in 87% isolated yield. 
